The authors regret that the acknowledgements of SNA were funded by SABER IRACDA program 2k12GM111726 was inadvertently left out of the article.
. 2022 Jan 19;18:103. doi: 10.1016/j.ijpddr.2022.01.003
Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
Philip T LoVerde
a,b,∗, Sevan N Alwan
a, Alexander B Taylor
a, Jayce Rhodes
c, Frédéric D Chevalier
d, Timothy Jc Anderson
e, Stanton F McHardy
c
Philip T LoVerde
aDepartments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
bPathology and Laboratory Medicine, The University of Texas Health Science Center, San Antonio, TX, USA
Find articles by Philip T LoVerde
Sevan N Alwan
aDepartments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
Find articles by Sevan N Alwan
Alexander B Taylor
aDepartments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
Find articles by Alexander B Taylor
Jayce Rhodes
cCenter for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA
Find articles by Jayce Rhodes
Frédéric D Chevalier
dProgram in Host-Pathogen Interactions, Texas Biomedical Research Institute, San Antonio, TX, USA
Find articles by Frédéric D Chevalier
Timothy Jc Anderson
eProgram in Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX, USA
Find articles by Timothy Jc Anderson
Stanton F McHardy
cCenter for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA
Find articles by Stanton F McHardy
aDepartments of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, USA
bPathology and Laboratory Medicine, The University of Texas Health Science Center, San Antonio, TX, USA
cCenter for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA
dProgram in Host-Pathogen Interactions, Texas Biomedical Research Institute, San Antonio, TX, USA
eProgram in Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX, USA
∗
Corresponding author. Departments of Biochemistry and Structural Biology, USA. loverde@uthscsa.edu
Collection date 2022 Apr.
© 2022 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC9254624 PMID: 35067439
This corrects the article "Rational approach to drug discovery for human schistosomiasis" in volume 16 on page 140.